Remnant cholesterol is a risk factor for metabolic syndrome and cardiovascular disease: a cross-sectional study

Author:

Jin Junguo1,Hu Xiangming1,Francois Melissa2,Zeng Ping1,Wang Weimian1,Yu Bingyan1,Zhou Yingling1,Dong Haojian1

Affiliation:

1. Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences

2. SUNY Upstate Medical University

Abstract

Abstract Background: Epidemiologic evidence suggested that remnant cholesterol (RC) is associated with the occurrence of cardiovascular disease (CVD). In recent years, RC has been connected with different types of cardiometabolic disorders. We aim to clarify the relationship among RC, metabolic syndrome (MetS) and subsequent CVD. Methods: We enrolled 7471 individuals into our study from China Health and Nutrition Survey in 2009 and followed participants till 2015. RC was calculated as total cholesterol minus low-density lipoprotein cholesterol minus high-density lipoprotein cholesterol. CVD was defined as myocardial infarction and stroke. Multivariate logistic regression models were used to evaluate the association between RC and MetS as well as CVD. The correlation between RC and MetS or its components were analyzed. We further investigated whether the association between RC and CVD was mediated by MetS. Results: Of all subjects, 24.73% were diagnosed with MetS and 3.58% developed CVD. Multivariate logistic regression analysis elucidated that the risk of MetS increased with RC tertiles and was elevated after adjusting all the confounder factors, (odds ratio: 3.50, 95% confidence interval: 3.22-3.80, P for trend <0.001). Meanwhile, we found that RC level is associated with the prevalence of all the components of MetS. Significant indirect effects of RC between MetS and CVD were found, with the index mediated at 60.90% of the association. Conclusions:Our study provides the evidence that RC level is independently associated with the prevalence of MetS and each component of MetS. MetS partially mediated the association between RC level and CVD risk.

Publisher

Research Square Platform LLC

Reference45 articles.

1. Cardiovascular diseases (CVDs). n.d. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (accessed October 18, 2022).

2. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis;Mottillo S;J Am Coll Cardiol,2010

3. The Global Epidemic of the Metabolic Syndrome;Saklayen MG;Curr Hypertens Rep,2018

4. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021;Fahed G;Int J Mol Sci,2022

5. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease;Ridker PM;N Engl J Med,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3